Literature DB >> 8039890

Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308.

M G Stevens1, S C Olsen, G W Pugh, M V Palmer.   

Abstract

Immune and pathologic responses were measured for 20 weeks after infection of mice with Brucella abortus 19, RB51, or 2308. Live bacteria and bacterial antigens of 19 and RB51 persisted in spleens for 10 and 4 weeks after infection, respectively, whereas 2308 bacteria and bacterial antigens persisted for at least 20 weeks. Small germinal centers and profound lymphoid depletion occurred in spleens of mice during the first 4 weeks of infection with strain 19 or 2308; however, mice infected with strain RB51 had much larger germinal centers but no lymphoid depletion. At 4 weeks, only spleen cells from RB51-infected mice proliferated when incubated with 2308 bacteria. Large germinal centers in the spleen and spleen cell proliferative responses to 2308 did not appear in strain 19-infected mice until 6 weeks or in strain 2308-infected mice until 10 weeks. Similar proliferative responses to 2308 occurred in mice infected with strain 19 or RB51 at 6 weeks and in mice infected with strain 19, RB51, or 2308 at 10 weeks. However, at 20 weeks, spleen cell proliferative responses to 2308 occurred in mice infected with strain 19 or 2308 but not in mice infected with strain RB51. Mice infected with strain RB51 had lower and less persistent antibody titers to 2308 than did mice infected with strain 19 or 2308. Collectively, these results indicate that RB51-infected mice have less persistent immune responses to 2308 than do mice infected with 19 or 2308. The shorter duration of the responses probably resulted because RB51 is considerably less pathogenic and is cleared more rapidly from mice than are 19 and 2308.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039890      PMCID: PMC302947          DOI: 10.1128/iai.62.8.3206-3212.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Interactions between mononuclear phagocytes and Brucella abortus strains of different virulence.

Authors:  W BRAUN; A POMALES-LEBRON; W R STINEBRING
Journal:  Proc Soc Exp Biol Med       Date:  1958-02

2.  Identification of Brucella abortus in formalin-fixed, paraffin-embedded tissues of cows, goats, and mice with an avidin-biotin-peroxidase complex immunoenzymatic staining technique.

Authors:  V P Meador; L B Tabatabai; W A Hagemoser; B L Deyoe
Journal:  Am J Vet Res       Date:  1986-10       Impact factor: 1.156

3.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Macrophage activation during experimental murine brucellosis. III. Do macrophages exert feedback control during brucellosis?

Authors:  C Cheers; H Pavlov; C Riglar; E Madraso
Journal:  Cell Immunol       Date:  1980-01       Impact factor: 4.868

5.  Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus.

Authors:  L N Araya; P H Elzer; G E Rowe; F M Enright; A J Winter
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

6.  Comparative histopathology in BALB/c mice infected with virulent and attenuated strains of Brucella abortus.

Authors:  F M Enright; L N Araya; P H Elzer; G E Rowe; A J Winter
Journal:  Vet Immunol Immunopathol       Date:  1990-10       Impact factor: 2.046

7.  Survival of rough and smooth strains of Brucella abortus in bovine mammary gland macrophages.

Authors:  B G Harmon; L G Adams; M Frey
Journal:  Am J Vet Res       Date:  1988-07       Impact factor: 1.156

8.  Outer membrane proteins from rough strains of four Brucella species.

Authors:  J M Santos; D R Verstreate; V Y Perera; A J Winter
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

9.  Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308.

Authors:  G W Pugh; E S Zehr; V P Meador; M Phillips; T J McDonald; B L Deyoe
Journal:  Am J Vet Res       Date:  1989-03       Impact factor: 1.156

10.  Monoclonal antibodies to Brucella surface antigens associated with the smooth lipopolysaccharide complex.

Authors:  G G Schurig; C Hammerberg; B R Finkler
Journal:  Am J Vet Res       Date:  1984-05       Impact factor: 1.156

View more
  27 in total

1.  The NOD-scid IL2rγnull Mouse Model Is Suitable for the Study of Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Thomas A Ficht; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Deletion of znuA virulence factor attenuates Brucella abortus and confers protection against wild-type challenge.

Authors:  Xinghong Yang; Todd Becker; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Characterization of smooth lipopolysaccharides and O polysaccharides of Brucella species by competition binding assays with monoclonal antibodies.

Authors:  V Weynants; D Gilson; A Cloeckaert; A Tibor; P A Denoel; F Godfroid; J N Limet; J J Letesson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Immunological response to the Brucella abortus GroEL homolog.

Authors:  J Lin; L G Adams; T A Ficht
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments.

Authors:  J Pizarro-Cerdá; E Moreno; V Sanguedolce; J L Mege; J P Gorvel
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.

Authors:  M G Stevens; S C Olsen; G W Pugh; D Brees
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51.

Authors:  R Vemulapalli; A J Duncan; S M Boyle; N Sriranganathan; T E Toth; G G Schurig
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Antibody responses to Brucella abortus 2308 in cattle vaccinated with B. abortus RB51.

Authors:  M G Stevens; S C Olsen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 10.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.